Menu

Articles by : William Newton, Associate Editor/Senior Writer

Breaking News

4th Circuit Again Sides with Drugmakers, Vacates Ruling Upholding Maryland’s 340B Contract Pharmacy Access Law

William Newton, Associate Editor/Senior Writer 340B Report Views
The U.S. 4th Circuit Court of Appeals
A three-judge panel of the U.S. 4th Circuit Court of Appeals decided 2-1 to overturn a lower court ruling in favor of Maryland's 340B contract pharmacy access law.
A Virginia federal appeals court today overturned a lower court ruling that had allowed Maryland to enforce its 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

AstraZeneca Becomes Latest Manufacturer to Announce 340B In-House Pharmacy Data Requirements

William Newton, Associate Editor/Senior Writer 340B Report Views
AstraZeneca announced it will require 340B providers to submit claims data on all 340B dispenses, including at in-house pharmacies, beginning May 1.
U.K.-based pharmaceutical giant AstraZeneca on Monday announced plans to require all 340B providers to submit claims data on 340B use [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

Minnesota, Connecticut Lawmakers Advance 340B Contract Pharmacy Access Bills

William Newton, Associate Editor/Senior Writer 340B Report Views
Minnesota and Connecticut state capitols
State legislators in Minnesota and Connecticut recently voted to advance 340B contract pharmacy access bills.
Minnesota state senators recently approved a bill that would strengthen the state’s existing 340B contract pharmacy access law, while Connecticut [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

News Alert

Federal Appeals Court Rejects Two More Drugmaker Challenges to Mississippi’s 340B Contract Pharmacy Access Law

William Newton, Associate Editor/Senior Writer 340B Report Views
The U.S. 5th Circuit Court of Appeals in New Orleans
A New Orleans federal appeals court yesterday upheld two lower court rulings in favor of Mississippi's 340B contract pharmacy access law.
A New Orleans federal appeals court on Thursday rejected two more manufacturer challenges to Mississippi’s 340B contract pharmacy access law, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

U.S. Government Asks 5th Circuit to Overturn Decision Upholding Louisiana’s 340B Contract Pharmacy Access Law

William Newton, Associate Editor/Senior Writer 340B Report Views
U.S. Department of Justice headquarters
The U.S. Department of Justice recently urged a federal appeals court to reconsider its decision to uphold a state 340B contract pharmacy access law.
The federal government on Tuesday urged a New Orleans federal appeals court to reconsider its decision upholding Louisiana’s 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

News Alert

Major Drugmaker Sues HRSA to Narrow 340B Patient Definition

William Newton, Associate Editor/Senior Writer 340B Report Views
AbbVie sign
AbbVie filed a lawsuit in a Washington, D.C. federal district court, alleging that HRSA's definition of a 340B patient is "overly broad."
Pharmaceutical giant AbbVie today filed a federal lawsuit challenging the Health Resources and Services Administration’s (HRSA) definition of a 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

News Alert

Patients Rising Ends Outreach Campaign After 340B Report Highlights Identical HRSA 340B RFI Submissions

William Newton, Associate Editor/Senior Writer 340B Report Views
A side-by-side of a Patients Rising template and an RFI comment.
Patients Rising said it is ending an outreach campaign tied to HRSA’s 340B rebate RFI after 340B Report found that most RFI comments published so far are identical submissions closely resembling Patients Rising's template.
Patients Rising said it has stopped an outreach effort tied to the Health Resources and Services Administration’s (HRSA) 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

Exclusive

Most Stakeholder Comments on 340B Rebate RFI So Far Are Duplicates Linked to Pharma-Funded Patient Group’s Template

William Newton, Associate Editor/Senior Writer 340B Report Views
A side-by-side of a Patients Rising template and an RFI comment.
More than half of early comments on HRSA’s 340B rebate RFI were identical submissions closely mirroring language from a Patients Rising template.
The Health Resources and Services Administration (HRSA) has published the first batch of stakeholder comments on its latest 340B rebate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

CMS Extends Deadline for Hospitals to Complete Medicare Drug Cost Survey with Significant 340B Implications

William Newton, Associate Editor/Senior Writer 340B Report Views
CMS on a screen
CMS recently extended the deadline for hospitals paid under OPPS to complete a Medicare drug cost acquisition survey.
The Centers for Medicare & Medicaid Services (CMS) has extended the deadline for hospitals to complete a controversial Medicare drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »

State Contract Pharmacy Lawsuit Roundup: Hearings in the Dakotas, Actions in Tennessee, Oregon, Oklahoma

William Newton, Associate Editor/Senior Writer 340B Report Views
A photo of a gavel next to a judge
Key actions occurred in litigation over state 340B contract pharmacy laws in North and South Dakotas, Tennessee, Oregon and Oklahoma.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live

; ?>